HALEY MURPHY: Open Payments
NPI 1124734819 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 27 payments from 13 companies in 2025. Trend: 2023 $339 · 2024 $623 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $189 |
| Lilly USA, LLC | 3 | $44 |
| Novo Nordisk Inc | 2 | $42 |
| SHIELD THERAPEUTICS INC | 2 | $31 |
| Verity Pharmaceuticals Inc. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| Dynavax Technologies Corporation | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: UBRELVY, QULIPTA, ACCRUFER, Tlando, Wegovy, OFEV, Ozempic, Veozah.
Industry payments across KY — which companies pay providers there.
